DOI: https://dx.doi.org/10.18203/2320-6012.ijrms20220539
Published: 2022-02-25

Rediscovering the cardiorenal syndrome: from theory to practice

José Miguel Huerta-Velázquez, Alexa Jimenez-Curiel, Daniel Felipe Santiago-Maciel

Abstract


Cardiorenal syndrome (CRS) is a state of advanced involvement that occurs between the heart and the kidneys, with both organs being affected by multiple causes, either secondary to a systemic pathology, or the dysfunction of one of these organs causing dysfunction on the other, acutely or chronically. Typically, there are five different types with different pathophysiology, but with the same purpose: cardiac and renal involvement. Epidemiological data from meta-analysis carried out around the world indicate that it is a very common pathology, yet commonly missed by clinicians. In patients with kidney or heart disease, which places them in a position to develop the syndrome, the first contact doctor must actively search for the diagnosis. In hospitalized patients, especially among those with previous cardiac or renal pathology, this syndrome has an important relevance, since its incidence is very high and early diagnosis is extremely important for an adequate treatment and thus avoid the perpetuation of damage to both organs. An early diagnosis can reduce the mortality rate, since it has been estimated that it increases by approximately 15% for every 10 ml / min reduction in GFR.


Keywords


Cardiorenal syndrome, Heart failure, Renal failure, Neurohumoral blockade

Full Text:

PDF

References


Krumholz HM, Chen YT, Vaccarino V. Correlates and impact on outcomes of worsening renal function in patients 65 years of age with heart failure. Am J Cardiol. 2000;85:1110-3.

Dizeo C, Chirino A, Franchi V, Álvarez S, Forcinito D, Trejo G et al. Cardiorenal syndrome as a predictor of poor in-hospital evolution in elderly patients hospitalized with heart failure. Heart failure. 2012;7.

Prothasis M, Varma A, Gaidhane S, Kumar S, Khatib N, Zahiruddin QS et al. Prevalence, types, risk factors, and outcomes of cardiorenal syndrome in a rural population of central India: A cross-sectional study. J Family Med Prim Care. 2020;9:4127-33.

Barros A. Cardiorenal syndrome. Current science. 2012;2:44-52.

Pereira-Rodríguez JE, Boada-Morales L, Niño-Serrato DR, Caballero-Chavarro M, Rincón-González G, Jaimes-Martín T, et al. Cardiorenal syndrome. Rev colomb cardiol. 2017;24(6):602-13.

Smith GL, Lichtman JH, Bracken MB. Renal impairment and outcomes in heart failure: systematic review and meta-analysis. J Am Coll Cardiol. 2006;47:1987.

Ezekowitz J, McAlister FA, Humphries KH. The association among renal insufficiency, pharmacotherapy, and outcomes in 6,427 patients with heart failure and coronary artery disease. J Am Coll Cardiol. 2004;44:1587.

Adams KF Jr, Fonarow GC, Emerman CL. Characteristics and outcomes of patients hospitalized for heart failure in the United States: rationale, design, and preliminary observations from the first 100,000 cases in the Acute Decompensated Heart Failure National Registry (ADHERE). Am Heart J. 2005;149:209.

Smith GL, Lichtman JH, Bracken MB. Renal impairment and outcomes in heart failure: systematic review and meta-analysis. J Am Coll Cardiol. 2006;47:1987.

Heywood JT, Fonarow GC, Costanzo MR. High prevalence of renal dysfunction and its impact on outcome in 118,465 patients hospitalized with acute decompensated heart failure: a report from the ADHERE database. J Card Fail. 2007;13:422.

Logeart D, Tabet JY, Hittinger L. Transient worsening of renal function during hospitalization for acute heart failure alters outcome. Int J Cardiol. 2008;127:228.

Damman K, Navis G, Voors AA. Worsening renal function and prognosis in heart failure: systematic review and meta-analysis. J Card Fail. 2007;13:599.

Cowie MR, Komajda M, Murray-Thomas T. Prevalence and impact of worsening renal function in patients hospitalized with decompensated heart failure: results of the prospective outcomes study in heart failure (POSH). Eur Heart J. 2006;27:1216.

Smith GL, Vaccarino V, Kosiborod M. Worsening renal function: what is a clinically meaningful change in creatinine during hospitalization with heart failure? J Card Fail. 2003;9:13.

Butler J, Forman DE, Abraham WT. Relationship between heart failure treatment and development of worsening renal function among hospitalized patients. Am Heart J. 2004;147:331.

Forman DE, Butler J, Wang Y. Incidence, predictors at admission, and impact of worsening renal function among patients hospitalized with heart failure. J Am Coll Cardiol. 2004;43:61.

Beldhuis IE, Streng KW, van der Meer P. Trajectories of Changes in Renal Function in Patients with Acute Heart Failure. J Card Fail. 2019;25:866.

Heywood JT, Fonarow GC, Costanzo MR. High prevalence of renal dysfunction and its impact on outcome in 118,465 patients hospitalized with acute decompensated heart failure: a report from the ADHERE database. J Card Fail. 2007;13:422.

Lassus J, Harjola VP, Sund R. Prognostic value of cystatin C in acute heart failure in relation to other markers of renal function and NT-proBNP. Eur Heart J. 2007;28:1841.

Smith GL, Lichtman JH, Bracken MB. Renal impairment and outcomes in heart failure: systematic review and meta-analysis. J Am Coll Cardiol. 2006;47:1987.

Rangaswami. Cardiorenal Syndrome: Classification, Pathophysiology, Diagnosis, and Treatment Strategies. A Scientific Statement From the American Heart Association. Circulation. 2019;139:e840-78.

Ismail Y, Kasmikha Z, Green HL. Cardiorrenal syndrome type 1: epidemiology, pathophysiology, and treatment. Semin Nephrol. 2012;32:18-25.